NCT07076680 2025-11-28
A Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer
SciClone Pharmaceuticals
Withdrawn
SciClone Pharmaceuticals
The First Hospital of Jilin University
Fudan University
Fudan University
Zhejiang Cancer Hospital
Monash University
European Institute of Oncology
Vastra Gotaland Region
Samsung Medical Center
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio